New Standard Operating Procedure: Measurement and Analysis of Mitochondrial Function In Situ in Permeabilized Muscle Fibers

New Standard Operating Procedure: Measurement and Analysis of Mitochondrial Function In Situ in Permeabilized Muscle Fibers

We are excited to announce the release of our latest Standard Operating Procedure (SOP) titled “Measurement and Analysis of Mitochondrial Function In Situ in Permeabilized Muscle Fibers”, developed by our Basic Science Trainee Commitee members Dr. Sean Ng and Magda Lensinski. The SOP aims to provide a comprehensive, step-by-step protocol using the Oroboros O2k high-resolution respirometry system to precisely measure and analyze cellular oxygen consumption, mitochondrial function, and bioenergetic efficiency, particularly in dystrophic skeletal muscle.

This new resource provides detailed methods covering permeabilized muscle fiber bundle preparation, chamber calibration, experimental titrations (pyruvate, malate, ADP titration, glutamate, cytochrome c, and succinate), and data analysis using DatLab software. Researchers can use this protocol to assess mitochondrial respiration, oxidative phosphorylation, and metabolic flexibility in health and disease states.

Visit our SOP Library to check it out

New Standard Operating Procedure: Measurement and Analysis of Mitochondrial Function In Situ in Permeabilized Muscle Fibers

Read next...

CPNG 2026

Zolgensma® Safety Update and CPNG Guidance for Families

The Canadian Pediatric Neuromuscular Group (CPNG) has issued a statement for families regarding recent reports of tumours in children treated with Zolgensma® (onasemnogene abeparvovec) gene therapy for spinal muscular atrophy (SMA). The statement outlines current evidence, considerations for follow-up care, and information for families and healthcare providers.

2026 Trainee Publication of the Year Awardee Spotlight on Jules Granet

Could You Be Our Next Awardee? Meet Jules Granet, NMD4C’s 2026 Publication of the Year Awardee

Nominations are open till by 18 January 2027!
In 2026, Jules Granet, a PhD Candidate at McGill University and trainee in Dr. Natasha Chang’s laboratory received an NMD4C Publication of the Year Award for research investigating how muscle stem cell dysfunction contributes to impaired muscle regeneration in Duchenne muscular dystrophy. Nominate yourself or a neuromuscular colleague whose research, clinical care, leadership, advocacy, or community contributions deserve to be recognized.

Save the date: 8th Ottawa International Conference On Neuromuscular Disease & Biology

Early Bird Registration Now Open: 8th Ottawa International Conference On Neuromuscular Disease & Biology

We are happy to announce that early bird registration is now open for the 8th Ottawa International Conference On Neuromuscular Disease & Biology which will be held on October 14-16, 2027 at the Fairmont Château Laurier in Ottawa, Canada. Now under the leadership of NMD4C Investigators; Dr. Mireille Khacho, Dr. Hanns Lochmuller, Dr. Bernard Jasmin, and Dr. Rashmi Kothary.